- Home
- PSTX vs ARDC Comparison
PSTX vs ARDC Comparison
Compare PSTX & ARDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTX
- ARDC
- Stock Information
- Founded
- PSTX 2014
- ARDC 2012
- Country
- PSTX United States
- ARDC United States
- Employees
- PSTX N/A
- ARDC N/A
- Industry
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- ARDC Investment Managers
- Sector
- PSTX Health Care
- ARDC Finance
- Exchange
- PSTX Nasdaq
- ARDC Nasdaq
- Market Cap
- PSTX 360.4M
- ARDC 342.8M
- IPO Year
- PSTX 2020
- ARDC N/A
- Fundamental
- Price
- PSTX $2.71
- ARDC $15.27
- Analyst Decision
- PSTX Strong Buy
- ARDC
- Analyst Count
- PSTX 2
- ARDC 0
- Target Price
- PSTX $15.00
- ARDC N/A
- AVG Volume (30 Days)
- PSTX 557.2K
- ARDC 115.8K
- Earning Date
- PSTX 11-07-2024
- ARDC 01-01-0001
- Dividend Yield
- PSTX N/A
- ARDC 9.84%
- EPS Growth
- PSTX N/A
- ARDC N/A
- EPS
- PSTX N/A
- ARDC N/A
- Revenue
- PSTX $150,858,000.00
- ARDC N/A
- Revenue This Year
- PSTX $64.38
- ARDC N/A
- Revenue Next Year
- PSTX N/A
- ARDC N/A
- P/E Ratio
- PSTX N/A
- ARDC N/A
- Revenue Growth
- PSTX 203.18
- ARDC N/A
- 52 Week Low
- PSTX $1.87
- ARDC $11.56
- 52 Week High
- PSTX $4.27
- ARDC $14.30
- Technical
- Relative Strength Index (RSI)
- PSTX 46.81
- ARDC 59.98
- Support Level
- PSTX $2.63
- ARDC $14.92
- Resistance Level
- PSTX $2.82
- ARDC $15.08
- Average True Range (ATR)
- PSTX 0.33
- ARDC 0.15
- MACD
- PSTX -0.03
- ARDC 0.04
- Stochastic Oscillator
- PSTX 19.86
- ARDC 88.66
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.
About ARDC Ares Dynamic Credit Allocation Fund Inc.
Ares Dynamic Credit Allocation Fund Inc is a closed-ended, diversified management investment company. The fund's investment objective is to provide an attractive level of total return, through current income and, secondarily, through capital appreciation. The Fund invests in a broad, dynamically managed portfolio of senior secured loans (Senior Loans) made to companies whose debt is rated below investment grade; corporate bonds (Corporate Bonds) that are high yield issues rated below investment grade; other fixed-income instruments of a similar nature that may be represented by derivatives; and securities of collateralized loan obligations (CLOs).